MARK D WEBER
Allopathic & Osteopathic Physicians|Family Medicine JACKSONVILLE, FL NPI 1295048296
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine FL Novo Nordisk AS All categories
General Payments — all program years on this page
$4,311.53
- Category: General Payments
- Program years: PY2019–2024
- Record count: 245
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,880.54 across 105 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,880.54 | 105 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $386.26 | 25 |
| ABBVIE INC. | $317.50 | 20 |
| Corcept Therapeutics | $262.20 | 12 |
| Lilly USA, LLC | $183.73 | 10 |
| Acerta Pharma LLC | $131.99 | 8 |
| GlaxoSmithKline, LLC. | $101.49 | 6 |
| Exact Sciences Corporation | $58.61 | 4 |
| Axsome Therapeutics, Inc. | $57.22 | 2 |
| Astellas Pharma US Inc | $49.72 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $47.42 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.85 | 2 |
| Merck Sharp & Dohme Corporation | $37.29 | 2 |
| Philips Electronics North America Corporation | $31.01 | 1 |
| DEXCOM, INC. | $28.46 | 2 |
| Xeris Pharmaceuticals, Inc. | $23.24 | 1 |
| Phathom Pharmaceuticals, Inc. | $22.92 | 1 |
| Abbott Laboratories | $22.28 | 1 |
| Daiichi Sankyo Inc. | $21.16 | 1 |
| CeQur Corporation | $19.56 | 1 |
| SANOFI-AVENTIS U.S. LLC | $19.10 | 1 |
| ITI, Inc. | $16.53 | 1 |
By program year
Records — PY2024 (105)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.